Publications
Ippolito G, Levy JA, Sonnerborg A, Mugusi F, Dianzani F. AIDS and HIV Infection after Thirty Years. AIDS research and treatment. 2013. PMID: 23365727
Chari A, Pri-Chen H, Jagannath S. Complete remission achieved with single agent CNTO 328, an anti-IL-6 monoclonal antibody, in relapsed and refractory myeloma. Clinical lymphoma, myeloma & leukemia. 2013. PMID: 23313067
Ang CS, Kelley RK, Choti MA, Cosgrove DP, Chou JF, Klimstra D, Torbenson MS, Ferrell L, Pawlik TM, Fong Y, O'Reilly EM, Ma J, McGuire J, Vallarapu GP, Griffin A, Stipa F, Capanu M, Dematteo RP, Venook AP, Abou-Alfa GK. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointestinal cancer research : GCR. 2013. PMID: 23505572
Kelley RK, Venook AP. Novel therapeutics in hepatocellular carcinoma: how can we make progress? American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013. PMID: 23714481
Kelley RK, Venook AP. Novel therapeutics in hepatocellular carcinoma: how can we make progress? American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013. PMID: 23714481
Venook AP, Saltz LB. Biologic agents in the treatment of colorectal cancer: the last decade; the lost decade? American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013. PMID: 23714476
Vahdat LT, Rugo HS, Perez EA. New developments in metastatic breast cancer: general discussion. Clinical advances in hematology & oncology : H&O. 2013. PMID: 24765684
Kaplan LD. Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. Volume 2013 Hematology. American Society of Hematology. Education Program. 2013. PMID: 24319170
Perez EA, Rugo HS, Vahdat LT. New developments in metastatic breast cancer: integrating recent data into clinical practice. Clinical advances in hematology & oncology : H&O. 2013. PMID: 24892840
Biran N, Jagannath S, Chari A. Risk stratification in multiple myeloma, part 2: the significance of genetic risk factors in the era of currently available therapies. Clinical advances in hematology & oncology : H&O. 2013. PMID: 24518521
Rugo HS. New developments in metastatic breast cancer: introduction. Clinical advances in hematology & oncology : H&O. 2013. PMID: 24637554
GBD 2010 Country Collaboration. The Lancet GBD 2010 Country Results: a Global Public Good. 2013. PMID:
Smith CC, Shah NP. The role of kinase inhibitors in the treatment of patients with acute myeloid leukemia. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013. PMID: 23714533
Smith CC, Shah NP. The role of kinase inhibitors in the treatment of patients with acute myeloid leukemia. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013. PMID: 23714533
Shah SK, Hull SC, Spinner MA, Berkman BE, Sanchez LA, Abdul-Karim R, Hsu AP, Claypool R, Holland SM. What does the duty to warn require? The American journal of bioethics : AJOB. 2013. PMID: 24024817
Ang CS, Kelley RK, Choti MA, Cosgrove DP, Chou JF, Klimstra D, Torbenson MS, Ferrell L, Pawlik TM, Fong Y, O'Reilly EM, Ma J, McGuire J, Vallarapu GP, Griffin A, Stipa F, Capanu M, Dematteo RP, Venook AP, Abou-Alfa GK. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointestinal cancer research : GCR. 2013. PMID: 23505572
Dunavin NC, Wei L, Elder P, Phillips GS, Benson DM, Hofmeister CC, Penza S, Greenfield C, Rose KS, Rieser G, Merritt L, Ketcham J, Heerema N, Byrd JC, Devine SM, Efebera YA. Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma. Volume 54 of Issue 8 Leukemia & lymphoma. 2012. PMID: 23194056
Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, Breslin TM, Hudis CA, Javid SH, Rugo HS, Silver SM, Lepisto EM, Weeks JC. Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. Journal of the National Cancer Institute. 2012. PMID: 23264681
Atreya CE, Ostrem JM, and Kelley RK.. Personalized Medicine in Oncology KRAS and Colorectal Cancer: Shades of Gray.. 2012. PMID:
Ruark E, Snape K, Humburg P, Loveday C, Bajrami I, Brough R, Rodrigues DN, Renwick A, Seal S, Ramsay E, Duarte Sdel V, Rivas MA, Warren-Perry M, Zachariou A, Campion-Flora A, Hanks S, Murray A, Ansari Pour N, Douglas J, Gregory L, Rimmer A, Walker NM, Yang TP, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Eccles D, Evans DG, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Gore M, Houlston R, Brown MA, Caufield MJ, Deloukas P, McCarthy MI, Todd JA, Breast and Ovarian Cancer Susceptibility Collaboration, Wellcome Trust Case Control Consortium, Turnbull C, Reis-Filho JS, Ashworth A, Antoniou AC, Lord CJ, Donnelly P, Rahman N. Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature. 2012. PMID: 23242139